ParkerVision, Inc.'s SEC filings document an OTCQB-traded Florida corporation focused on proprietary RF technologies, wireless applications, licensing, and patent enforcement. Its 8-K filings report operating results, legal and appellate developments involving patent claims, and material events that affect the company's capital structure and disclosure record.
The filing record also covers registered direct common stock offerings under a Form S-3 shelf registration statement, exchanges of convertible promissory notes for common stock, unregistered equity issuance disclosures, and executive compensation arrangements under the company's long-term incentive plan. These documents address governance approvals, share-based awards, financing terms, and risk references tied to patent proceedings and funding activity.
ParkerVision Inc. (PRKR) reports director William George Walters' direct common-stock holdings. A footnote says shares were granted under the company's 2019 Long-Term Incentive Plan as board compensation, with a fair value of approximately $40,000. Two listed holding entries are dated October 23, 2026.
ParkerVision’s prospectus permits selling shareholders to resell up to 9,387,500 shares of common stock. This comprises 2,843,750 shares previously issued, 6,343,750 shares issuable upon conversion of convertible notes and for interest payments, and 200,000 shares issuable upon option exercise. The notes have a fixed conversion price of $0.16 per share.
ParkerVision will not receive proceeds from the resales. If the options are exercised for cash, it will receive up to $42,620 in gross proceeds and expects to use any proceeds for general working capital. Separately, ParkerVision expanded its board from four to five members on October 23, 2026, and unanimously appointed William G. Walters to the new vacancy. He will receive the company’s standard non-employee director compensation.
ParkerVision, Inc.'s Prospectus Supplement No. 52 updates a prospectus permitting selling shareholders to resell up to 16,638,353 shares of common stock issuable upon conversion of, and for payment of interest from time to time at the company's option for, convertible promissory notes dated between May 10, 2022 and August 3, 2022. The notes have a fixed conversion price of $0.13 per share. The supplement adds information from a current report dated October 29, 2026.
On October 23, 2026, ParkerVision's board expanded from four to five members and unanimously appointed William G. Walters to the resulting Class II director vacancy. Walters will receive the company's standard non-employee director compensation, and ParkerVision entered into its standard indemnification agreement with him.
ParkerVision, Inc.'s prospectus permits the selling stockholder to resell up to 1,578,946 shares of common stock. This comprises 1,052,631 common shares and 526,315 shares underlying Warrants. ParkerVision will receive no proceeds from the selling stockholder's sales; if Warrants are exercised for cash, it may receive up to $526,315 in gross proceeds, which it expects to use for general working capital, including litigation expenses.
On October 23, 2026, ParkerVision expanded its board from four to five members and unanimously appointed William G. Walters to fill the Class II director vacancy. Walters will receive the company's standard non-employee director compensation.
ParkerVision, Inc. (PRKR) permits selling stockholders to resell up to 13,342,953 shares of common stock. ParkerVision will not receive proceeds from those resales; if the warrants are exercised for cash, it could receive up to $2,833,756 in gross proceeds for general working capital, including litigation expenses.
The accompanying report states that on October 23, 2026, ParkerVision’s board expanded from four to five members and unanimously appointed William G. Walters to fill the resulting director vacancy. He will receive the company’s standard non-employee director compensation arrangements.
ParkerVision, Inc.'s prospectus permits selling stockholders to resell up to 5,871,584 shares of common stock. ParkerVision will not receive proceeds from those sales. On October 23, 2026, the board expanded from four to five members, creating a Class II director vacancy, and unanimously appointed William G. Walters to fill it. Walters, age 89, is retired from an investment banking career focused on micro and small cap companies and will receive the company's standard non-employee director compensation. ParkerVision entered into its standard indemnification agreement with him.
ParkerVision, Inc. (PRKR) updated its resale prospectus, which permits selling stockholders to resell up to 16,809,295 shares of common stock. The amount includes up to 4,961,538 shares issuable upon conversion of notes or for interest payments, 3,907,331 shares issued under securities purchase agreements, 2,740,426 shares issued for services and repayment of short-term loans and accounts payable, and up to 5,000,000 and 200,000 shares issuable upon warrant exercises at $0.74 and $1.00 per share, respectively.
ParkerVision receives no proceeds from selling-stockholder resales. Cash exercise of the warrants could provide up to $3,900,000 in gross proceeds for general working capital and corporate purposes. The update also reports that the board expanded from four to five members and appointed William G. Walters as a class II director; he will receive standard non-employee director compensation.
ParkerVision, Inc.’s prospectus permits selling stockholders to resell up to 18,014,164 shares of common stock. This includes up to 5,457,583 shares issuable upon conversion of Tranche 1 Notes at a fixed $0.10 per-share conversion price; up to 10,131,581 shares issuable upon conversion of Tranche 2 Notes at a fixed $0.08 per-share conversion price; 625,000 shares issued for consulting services; and up to 1,800,000 shares issuable upon exercise of a five-year warrant at $0.10 per share, subject to adjustment. ParkerVision receives no proceeds from stockholder resales; if the warrant is exercised for cash, it may receive up to $180,000 in gross proceeds for general working capital and corporate purposes. On October 23, 2026, the board expanded from four to five members and appointed William G. Walters as a class II director.
ParkerVision, Inc. (PRKR) states that its prospectus permits selling stockholders to resell up to 17,189,660 shares of common stock. ParkerVision receives no proceeds from those resales. If the 2016 Warrant is exercised for cash, the company will receive up to $700,000 in gross proceeds; it may receive up to an additional $1,763,500 from sales of its common stock or exercise of warrants issued to Aspire Capital. ParkerVision expects to use warrant-exercise proceeds, if any, for patent enforcement actions, working capital and general corporate purposes.
On October 23, 2026, the board expanded from four to five members and unanimously appointed William G. Walters to fill the resulting class II director vacancy. He will receive the company’s standard non-employee director compensation.
ParkerVision, Inc. (PRKR)'s prospectus permits the listed selling stockholders to resell up to 12,800,000 shares of Common Stock. The shares consist of up to 7,800,000 shares issuable upon conversion of convertible promissory notes and, at the company's option, for interest payments, plus 5,000,000 shares issuable upon exercise of a five-year warrant. Selling stockholders receive proceeds from resales; ParkerVision may receive up to $800,000 in gross proceeds if the warrant is exercised for cash. The company expects to use any such proceeds for patent enforcement actions and other working capital and general corporate purposes.
On October 23, 2026, ParkerVision's board expanded from four to five members and unanimously appointed William G. Walters to fill a Class II director vacancy. He will receive the company's standard non-employee director compensation, and the company entered into its standard indemnification agreement with him.